IRIS
PONTREMOLI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 27.766
AS - Asia 2.936
NA - Nord America 1.727
SA - Sud America 256
AF - Africa 42
OC - Oceania 10
Totale 32.737
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 27.233
US - Stati Uniti d'America 1.622
SG - Singapore 1.292
CN - Cina 769
VN - Vietnam 394
FR - Francia 239
BD - Bangladesh 187
BR - Brasile 157
HK - Hong Kong 111
FI - Finlandia 78
AR - Argentina 54
DE - Germania 54
CA - Canada 34
CH - Svizzera 34
GB - Regno Unito 34
MX - Messico 34
JP - Giappone 33
IN - India 25
IQ - Iraq 25
ID - Indonesia 16
NL - Olanda 16
ES - Italia 12
PK - Pakistan 12
PH - Filippine 11
RU - Federazione Russa 11
VE - Venezuela 11
CO - Colombia 10
IE - Irlanda 10
JM - Giamaica 10
UA - Ucraina 10
ZA - Sudafrica 9
AU - Australia 8
EC - Ecuador 8
SA - Arabia Saudita 8
PY - Paraguay 7
DZ - Algeria 6
PL - Polonia 6
TH - Thailandia 6
UZ - Uzbekistan 6
CL - Cile 5
CR - Costa Rica 5
MA - Marocco 5
PR - Porto Rico 5
AT - Austria 4
JO - Giordania 4
KE - Kenya 4
SN - Senegal 4
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
EG - Egitto 3
HN - Honduras 3
KR - Corea 3
LB - Libano 3
MK - Macedonia 3
MY - Malesia 3
NI - Nicaragua 3
NP - Nepal 3
PE - Perù 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BB - Barbados 2
CZ - Repubblica Ceca 2
GA - Gabon 2
GR - Grecia 2
IR - Iran 2
KZ - Kazakistan 2
LT - Lituania 2
MN - Mongolia 2
OM - Oman 2
PT - Portogallo 2
TR - Turchia 2
TT - Trinidad e Tobago 2
BE - Belgio 1
BO - Bolivia 1
BW - Botswana 1
CI - Costa d'Avorio 1
DK - Danimarca 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
IL - Israele 1
KG - Kirghizistan 1
KH - Cambogia 1
KY - Cayman, isole 1
LK - Sri Lanka 1
LV - Lettonia 1
MR - Mauritania 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PA - Panama 1
PF - Polinesia Francese 1
RS - Serbia 1
SE - Svezia 1
SI - Slovenia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
Totale 32.735
Salva come PNG Salva come JPEG
Città #
Genova 16.085
Genoa 6.810
Rapallo 2.117
Vado Ligure 1.761
Singapore 637
San Jose 496
Lauterbourg 227
Ashburn 152
New York 149
Ho Chi Minh City 121
Council Bluffs 117
Beijing 111
Hong Kong 104
Milan 98
Hanoi 90
Helsinki 74
Santa Clara 63
Los Angeles 45
Bordighera 39
Frankfurt am Main 37
Zurich 32
Rome 30
Tokyo 29
Boardman 27
Naples 26
Buffalo 23
Mexico City 21
Tianjin 20
Orem 18
São Paulo 17
Turin 16
Florence 15
City of London 13
Da Nang 13
Amsterdam 12
Chicago 10
Dallas 10
St Louis 10
The Dalles 10
Toronto 10
Bari 9
Bologna 9
Dublin 9
Palermo 9
Baghdad 8
Biên Hòa 8
Haiphong 8
Nuremberg 8
Shanghai 8
Hải Dương 7
Kingston 7
Phoenix 7
San Francisco 7
Atlanta 6
Brooklyn 6
Cardiff 6
Guangzhou 6
Madrid 6
North Charleston 6
Buenos Aires 5
Can Tho 5
Charlotte 5
Kyiv 5
Memphis 5
Padua 5
Philadelphia 5
Rio de Janeiro 5
San José 5
Sydney 5
Verona 5
Brescia 4
Bình Phước 4
Caracas 4
Columbus 4
Dakar 4
Goiânia 4
Jeddah 4
Johannesburg 4
Lahore 4
Las Vegas 4
Mumbai 4
Nairobi 4
Parma 4
Pescara 4
Shenzhen 4
Tampa 4
Tashkent 4
Thái Bình 4
Xi'an 4
Amman 3
Asunción 3
Baltimore 3
Bogotá 3
Bratislava 3
Bắc Ninh 3
Cape Town 3
Catalão 3
Cazzago San Martino 3
Chennai 3
Cincinnati 3
Totale 29.999
Salva come PNG Salva come JPEG
Nome #
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 330
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial 267
Left ventricular dilatation and subclinical renal damage in primary hypertension 255
Baseline hs-CRP predicts hypertension remission in metabolic syndrome 225
Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes 210
Metabolic syndrome is associated with left ventricular dilatation in primary hypertension 209
Achievement of therapeutic targets in patients with diabetes and chronic kidney disease: Insights from the Associazione Medici Diabetologi Annals initiative 208
Characteristics of current heart failure patients admitted to internal medicine vs. cardiology hospital units: the VASCO study 208
Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease 203
Early renal abnormalities as an indicator of cardiovascular risk in type 2 diabetes 202
Chronic kidney disease in hypertension under specialist care: the I-DEMAND study 200
ABNORMALITIES IN AMINO ACID METABOLISM IN CHRONIC RENAL FAILURE 198
Peripheral artery disease and blood pressure profile abnormalities in hemodialysis patients 197
Ambulatory arterial stiffness index and renal abnormalities in primary hypertension 197
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 189
Increased renal resistive index in patients with essential hypertension: a marker of target organ damage. 184
Uric Acid Promotes Apoptosis in Human Proximal Tubule Cells by Oxidative Stress and the Activation of NADPH Oxidase NOX 4 184
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 183
Uric acid and angiotensin II additively promote inflammation and oxidative stress in human proximal tubule cells by activation of toll-like receptor 4. 181
C-reactive protein and target organ damage in untreated patients with primary hypertension. 180
Antihyperglycemic treatment in patients with type 2 diabetes in Italy: The impact of age and kidney function 179
5,10-Methylenetetrahydrofolate reductase polymorphism and early organ damage in primary hypertension. 178
Antihypertensive Treatment and Renal Protection: the role of drugs inhibiting the renin-angiotensin-aldosterone system. 177
Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study 177
Causes and impact on survival of underuse of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in heart failure 176
Cardiovascular and renal effects of hyperuricaemia and gout. 175
Antihypertensive treatment and renal protection: Is there a J-curve relationship? 175
Metabolic syndrome is associated with early signs of organ damage in nondiabetic, hypertensive patients 174
Independent association of ECG abnormalities with microalbuminuria and renal damage in hypertensive patients without overt cardiovascular disease: data from Italy-Developing Education and awareness on MicroAlbuminuria in patients with hypertensive Disease study. 171
Changes in renal resistive index and urinary albumin excretion in hypertensive patients under long-term treatment with lisinopril or nifedipine GITS 171
Natural history and risk factors for diabetic kidney disease in patients with T2D: lessons from the AMD-annals 170
Antihypertensive Treatment in Diabetic Kidney Disease: The Need for a Patient-Centered Approach 170
Variability in HbA1c, blood pressure, lipid parameters and serum uric acid, and risk of development of chronic kidney disease in type 2 diabetes 169
Characterization of the calpastatin defect in erythrocytes from patients with essential hypertension. 168
The liver and the kidney: two critical organs influencing the atherothrombotic risk in metabolic syndrome. 167
Blood pressure variability and multiple organ damage in primary hypertension 167
Apparent Treatment Resistant Hypertension, Blood Pressure Control and the Progression of Chronic Kidney Disease in Patients with Type 2 Diabetes 167
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy 167
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 166
Renin–angiotensin–aldosterone system blockade in chronic kidney disease: current strategies and a look ahead 163
Mild hyperuricemia and subclinical renal damage in untreated primary hypertension 163
Effects of a protein meal on blood amino acid profile in patients with chronic renal failure. 163
Subclinical functional and structural renal abnormalities predict new onset type 2 diabetes in patients with primary hypertension 162
The role of calpain in the selective increased phosphorylation of the anion-transport protein in red cell of hypertensive subjects. 161
Impact of target organ damage assessment in the evaluation of global risk in patients with essential hypertension. 160
Predictors of renal complications in pediatric patients with type 1 diabetes mellitus: A prospective cohort study 160
Microalbuminuria in primary hypertension: a guide to optimal patient management? 159
Prevalence of micro- and macroalbuminuria and their relationship with other cardiovascular risk factors in essential hypertension. 158
Amino acid imbalance in patients with chronic renal failure. 157
Acute renal failure due to acute bilateral renal artery thrombosis: successful surgical revascularization after prolonged anuria. 154
Five-Year Predictors of Insulin Initiation in People with Type 2 Diabetes under Real-Life Conditions 154
Post-biopsy arteriovenous fistulas of the native kidneys diagnosed by Doppler US 153
Creatinine clearance and early signs of target organ damage in primary hypertension 152
Inappropriate left ventricular mass is associated with microalbuminuria independently of left ventricular hypertrophy in primary hypertension 152
Renal and cardiac abnormalities in primary hypertension 152
Combined effect of albuminuria and estimated glomerular filtration rate on cardiovascular events and all-cause mortality in uncomplicated hypertensive patients 151
Microalbuminuria identifies overall cardiovascular risk in essential hypertension: an artificial neural network-based approach. 151
Vitamin D modulates the association of circulating insulin-like growth factor-1 with carotid artery intima-media thickness 151
Sub-clinical organ damage in hypertension and obesity 151
Blood pressure levels and control in Italy: Comprehensive analysis of clinical data from 2000-2005 and 2005-2011 hypertension surveys 151
Adiponectin/leptin ratio predicts the remission of metabolic syndrome: A pilot study 150
Predicting cardiovascular risk using creatinine clearance and an artificial neural network in primary hypertension 150
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 150
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 150
Combined use of urinary neutrophil gelatinase-associated lipocalin (uNGAL) and albumin as markers of early cardiac damage in primary hypertension. 149
Increased ambulatory arterial stiffness index is associated with target organ damage in primary hypertension 148
Use of nifedipine in the treatment of hypertension. 147
Albuminuria: The kidney message on cardiovascular health 147
Coronary flow reserve is impaired in hypertensive patients with subclinical renal damage 147
Kidney dysfunction and related cardiovascular risk factors among patients with type 2 diabetes 147
Reliability of retinal microcirculation measurements by scanning laser Doppler flowmetry in humans 146
Role of the fixed-dose combination lercanidipine-enalapril in renal protection. 146
The calpastatin defect in hypertension is possibly due to a specific degradation by calpain. 146
Changes in albuminuria and cardiovascular risk under antihypertensive treatment: a systematic review and meta-regression analysis 146
Kidney disease measures are associated with the burden of coronary atherosclerosis, independently of diabetes 146
Application of Temporary Filter During Percutaneous Transcatheter Embolization with Macro Coils of High-flow Massive Renal Arteriovenous Fistula 145
Mild renal dysfunction and renal vascular resistance in primary hypertension 145
Plasma Triglycerides and HDL-C Levels Predict the Development of Diabetic Kidney Disease in Subjects With Type 2 Diabetes: The AMD Annals Initiative 145
Metabolic syndrome and ambulatory arterial stiffness index in non-diabetic patients with primary hypertension. 145
Insulin activation of red blood cell Na+/H+ exchange decreases the affinity of sodium sites. 144
Evaluation of subclinical organ damage for risk assessment and treatment in the hypertensive patient: role of microalbuminuria. 144
Renal ammoniagenesis in man with chronic potassium depletion. 144
Nephrolithiasis by Corynebacterium urealyticum infection: Literature review and case report 144
Hyperuricemia and renal risk 144
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity 144
Renal metabolism of amino acids in early insulin-dependent diabetes mellitus 143
METABOLIC SYNDROME AND CARDIOVASCULAR RISK IN PRIMARY HYPERTENSION. 143
Blood pressure status and the incidence of diabetic kidney disease in patients with hypertension and type 2 diabetes 143
Exploring New Options for Cardiovascular Disease Prevention May Improve Patients’ Quality of Life and Outcomes 143
Multiple venous sampling for catecholamine assay in the diagnosis of malignant pheochromocytoma 142
Highlights from International Congress 142
Can we predict outcome by noninvasive assessment of renal haemodynamics in hypertension? The role of renal resistive index 142
Uric acid lowering for slowing CKD progression after the CKD-FIX trial: a solved question or still a dilemma? 141
Overall health assessment: a renal perspective. 141
7A.09: METABOLIC SYNDROME IS ASSOCIATED WITH LEFT VENTRICULAR DILATATION IN PRIMARY HYPERTENSION 141
Midwall fractional shortening identifies extracardiac organ damage in essential hypertension 140
Increased urine semaphorin-3A is associated with renal damage in hypertensive patients with chronic kidney disease: a nested case-control study 139
Association of kidney disease measures with risk of renal function worsening in patients with hypertension and type 2 diabetes 139
Normoalbuminuric kidney impairment in patients with T1DM: Insights from annals initiative 139
Microalbuminuria and subclinical cerebrovascular damage in essential hypertension 138
Totale 16.527
Salva come PNG Salva come JPEG
Categoria #
all - tutte 106.210
article - articoli 105.209
book - libri 0
conference - conferenze 0
curatela - curatele 590
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 411
Totale 212.420
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021211 0 0 0 0 0 0 0 0 0 0 0 211
2021/20222.755 91 142 136 289 118 279 175 652 148 286 110 329
2022/20232.596 263 155 24 272 382 467 47 209 444 62 212 59
2023/20241.396 71 198 36 145 133 266 72 83 82 14 93 203
2024/20254.503 100 343 148 297 598 453 428 702 228 227 459 520
2025/20268.294 888 353 629 720 1.081 815 1.288 346 496 856 629 193
Totale 33.347